Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
2.
Mol Psychiatry ; 22(3): 346-352, 2017 03.
Article in English | MEDLINE | ID: mdl-28115739

ABSTRACT

Opioids are very effective analgesics, but they are also highly addictive. Methadone is used to treat opioid dependence (OD), acting as a selective agonist at the µ-opioid receptor encoded by the gene OPRM1. Determining the optimal methadone maintenance dose is time consuming; currently, no biomarkers are available to guide treatment. In methadone-treated OD subjects drawn from a case and control sample, we conducted a genome-wide association study of usual daily methadone dose. In African-American (AA) OD subjects (n=383), we identified a genome-wide significant association between therapeutic methadone dose (mean=68.0 mg, s.d.=30.1 mg) and rs73568641 (P=2.8 × 10-8), the nearest gene (306 kilobases) being OPRM1. Each minor (C) allele corresponded to an additional ~20 mg day-1 of oral methadone, an effect specific to AAs. In European-Americans (EAs) (n=1027), no genome-wide significant associations with methadone dose (mean=77.8 mg, s.d.=33.9 mg) were observed. In an independent set of opioid-naive AA children being treated for surgical pain, rs73568641-C was associated with a higher required dose of morphine (n=241, P=3.9 × 10-2). Similarly, independent genomic loci previously shown to associate with higher opioid analgesic dose were associated with higher methadone dose in the OD sample (AA and EA: n=1410, genetic score P=1.3 × 10-3). The present results in AAs indicate that genetic variants influencing opioid sensitivity across different clinical settings could contribute to precision pharmacotherapy for pain and addiction.


Subject(s)
Analgesics, Opioid/pharmacology , Opioid-Related Disorders/genetics , Pain/genetics , Adult , Black or African American/genetics , Alleles , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/therapeutic use , Dose-Response Relationship, Drug , Female , Gene Frequency , Genetic Predisposition to Disease/genetics , Genome-Wide Association Study/methods , Genotype , Humans , Male , Methadone/therapeutic use , Middle Aged , Morphine/therapeutic use , Pain/drug therapy , Polymorphism, Single Nucleotide/genetics , Receptors, Opioid, mu/genetics , United States , White People/genetics
3.
Mol Psychiatry ; 22(2): 242-249, 2017 02.
Article in English | MEDLINE | ID: mdl-27067016

ABSTRACT

Nicotine withdrawal symptoms contribute to relapse in smokers, thereby prolonging the harm caused by smoking. To investigate the molecular basis for this phenomenon, we conducted a genome-wide association study of DSM-IV nicotine withdrawal in a sample of African American (AA) and European American (EA) smokers. A combined AA and EA meta-analysis (n=8021) identified three highly correlated single nucleotide polymorphisms (SNPs) in the protocadherin (PCDH)-α, -ß and -γ gene cluster on chromosome 5 that were associated with nicotine withdrawal (P<5 × 10-8). We then studied one of the SNPs, rs31746, in an independent sample of smokers who participated in an intravenous nicotine infusion study that followed overnight smoking abstinence. After nicotine infusion, abstinent smokers with the withdrawal risk allele experienced greater alleviation of their urges to smoke, as assessed by the Brief Questionnaire on Smoking Urges (BQSU). Prior work has shown that the PCDH-α, -ß and -γ genes are expressed in neurons in a highly organized manner. We found that rs31746 mapped to a long-range neuron-specific enhancer element shown previously to regulate PCDH-α, -ß and -γ gene expression. Using Braincloud mRNA expression data, we identified a robust and specific association between rs31746 and PCDH-ß8 mRNA expression in frontal cortex tissue (P<1 × 10-5). We conclude that PCDH-α, -ß and -γ gene cluster regulatory variation influences the severity of nicotine withdrawal. Further studies on the PCDH-α, -ß and -γ genes and their role in nicotine withdrawal may inform the development of novel smoking cessation treatments and reduce the harm caused by tobacco smoking.


Subject(s)
Cadherins/genetics , Smoking/genetics , Substance Withdrawal Syndrome/genetics , Tobacco Use Disorder/genetics , Adult , Black or African American/genetics , Cadherins/metabolism , Diagnostic and Statistical Manual of Mental Disorders , Female , Gene Expression Regulation , Genome-Wide Association Study , Humans , Male , Multigene Family/genetics , Nicotine/metabolism , Polymorphism, Single Nucleotide/genetics , Protocadherins , Recurrence , Smoking Cessation , White People/genetics
4.
Mol Psychiatry ; 22(9): 1345-1351, 2017 09.
Article in English | MEDLINE | ID: mdl-27240527

ABSTRACT

The single-nucleotide polymorphism rs9804190 in the Ankyrin G (ANK3) gene has been reported in genome-wide association studies to be associated with bipolar disorder (BD). However, the neural system effects of rs9804190 in BD are not known. We investigated associations between rs9804190 and gray and white matter (GM and WM, respectively) structure within a frontotemporal neural system implicated in BD. A total of 187 adolescent and adult European Americans were studied: a group homozygous for the C allele (52 individuals with BD and 56 controls) and a T-carrier group, carrying the high-risk T allele (38 BD and 41 controls). Subjects participated in high-resolution structural magnetic resonance imaging and diffusion tensor imaging (DTI) scanning. Frontotemporal region of interest (ROI) and whole-brain exploratory analyses were conducted. DTI ROI-based analysis revealed a significant diagnosis by genotype interaction within the uncinate fasciculus (P⩽0.05), with BD subjects carrying the T (risk) allele showing decreased fractional anisotropy compared with other subgroups, independent of age. Genotype effects were not observed in frontotemporal GM volume. These findings support effects of rs9804190 on frontotemporal WM in adolescents and adults with BD and suggest a mechanism contributing to WM pathology in BD.


Subject(s)
Ankyrins/genetics , Bipolar Disorder/genetics , Bipolar Disorder/pathology , Gray Matter/pathology , White Matter/pathology , Adolescent , Adult , Ankyrins/metabolism , Bipolar Disorder/diagnostic imaging , Bipolar Disorder/metabolism , Brain/diagnostic imaging , Brain/pathology , Diffusion Tensor Imaging , Female , Gene Frequency , Genome-Wide Association Study , Gray Matter/diagnostic imaging , Gray Matter/metabolism , Humans , Magnetic Resonance Imaging/methods , Male , Nerve Net/diagnostic imaging , Nerve Net/pathology , Polymorphism, Single Nucleotide , Risk Factors , White Matter/diagnostic imaging , White Matter/metabolism
5.
Pharmacogenomics J ; 15(4): 340-6, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25532758

ABSTRACT

Stress and hormones released in response to stress influence the effects of nicotine and the severity of nicotine withdrawal. Here, we systematically examine the contribution of a stress response gene, FKBP5, to the acute and chronic behavioral effects of nicotine in smokers. Subjects were European- and African-American (EA and AA) heavy smokers who participated in an intravenous (IV) nicotine administration study (total n=169). FKBP5 rs3800373 genotype was analyzed for association to several outcomes, including nicotine withdrawal and the acute subjective, heart rate (HR), blood pressure and plasma cortisol responses to IV nicotine. Nicotine withdrawal was also examined in relation to rs3800373 allele frequencies in an independent cohort of EA and AA current smokers (n=3821). For a subset of laboratory subjects FKBP5 mRNA (n=48) expression was explored for an association to the same outcomes. The rs3800373 minor allele was associated with less severe nicotine withdrawal in laboratory subjects and the independent cohort of smokers. The rs3800373 minor allele was also associated with lower subjective ratings of negative drug effects in response to IV nicotine. Low FKBP5 mRNA expression was associated lower cortisol levels, lower subjective ratings of negative drug effects and a blunted HR response to nicotine. Stress hormone regulation via FKBP5 warrants further investigation as a potential contributor to the effects of nicotine withdrawal, which occurs commonly, and has an important role in the maintenance of smoking behavior and relapse following a quit attempt.


Subject(s)
Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Smoking/genetics , Tacrolimus Binding Proteins/genetics , Black or African American , Alleles , Blood Pressure/drug effects , Blood Pressure/genetics , Diagnostic and Statistical Manual of Mental Disorders , Gene Frequency , Genotype , Heart Rate/drug effects , Heart Rate/genetics , Humans , Hydrocortisone/blood , Injections, Intravenous , Nicotine/administration & dosage , Nicotinic Agonists/administration & dosage , RNA/biosynthesis , RNA/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Substance Withdrawal Syndrome/physiopathology , White People
6.
Transl Psychiatry ; 4: e353, 2014 Jan 28.
Article in English | MEDLINE | ID: mdl-24473444

ABSTRACT

Unbiased genome-wide approaches can provide novel insights into the biological pathways that are important for human behavior and psychiatric disorder risk. The association of α-endomannosidase gene (MANEA) variants and cocaine-induced paranoia (CIP) was initially described in a study that used a whole-genome approach. Behavioral effects have been reported for other mannosidase genes, but MANEA function in humans and the clinical potential of the previous findings remain unclear. We hypothesized that MANEA would be associated with psychiatric phenotypes unrelated to cocaine use. We used a multi-stage association study approach starting with four psychiatric disorders to show an association between a MANEA single-nucleotide polymorphism (SNP; rs1133503) and anxiety disorders. In the first study of 2073 European American (EA) and 2459 African American subjects mostly with comorbid drug or alcohol dependence, we observed an association in EAs of rs1133503 with panic disorder (PD) (191 PD cases, odds ratio (OR)=1.7 (95% confidence interval (CI): 1.22-2.41), P=0.002). We replicated this finding in an independent sample of 142 PD cases (OR =1.53 (95% CI: 1.00-2.31), P=0.043) and extended it in an independent sample of 131 generalized social anxiety disorder cases (OR=2.15 (95% CI: 1.27-3.64), P=0.004). MANEA alleles and genotypes were also associated with gene expression differences in whole blood cells. Using publically available data, we observed a consistent effect on expression in brain tissue. We conclude that pathways involving α-endomannosidase warrant further investigation in relation to anxiety disorders.


Subject(s)
Black or African American/genetics , Genome-Wide Association Study , Mannosidases/genetics , Membrane Proteins/genetics , Panic Disorder/genetics , Phobic Disorders/genetics , White People/genetics , Adult , Black or African American/statistics & numerical data , Blood Cells/metabolism , Brain/metabolism , Comorbidity , Female , Gene Expression/genetics , Humans , Male , Mannosidases/metabolism , Membrane Proteins/metabolism , Middle Aged , Panic Disorder/epidemiology , Phobic Disorders/epidemiology , Polymorphism, Single Nucleotide/genetics , Substance-Related Disorders/epidemiology , Substance-Related Disorders/genetics , United States/epidemiology , White People/statistics & numerical data , Young Adult
7.
Mol Psychiatry ; 14(4): 381-9, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18283276

ABSTRACT

Non-coding regulatory elements can transduce the human genome's response to environmental stimuli. Thus, there is a possibility that variation in non-coding regulatory elements may underlie some of the diversity in human behavior. However, this idea has remained largely untested due to the difficulty in accurately identifying regulatory elements in the 98% of the human genome that does not encode protein. The recent recognition that small trans-acting RNAs anneal to mRNA and regulate gene expression provides a means to identify and test such variants. Here, we show that microRNA-directed silencing of mRNA can be attenuated by a common human polymorphism. We have identified an element (A-element) within serotonin receptor 1B (HTR1B) mRNA that confers repression by miR-96. The repressive activity of this element is attenuated by a common human variant (G-element) that disrupts a nucleotide critical for its interaction with miR-96. Because deletion of the HTR1B gene leads to an aggressive phenotype in mice, we hypothesized an association between the A/G polymorphism and aggressive phenotypes in a sample of 359 college students. As predicted, individuals homozygous for the ancestral A-element reported more conduct-disorder behaviors than individuals with the G-element. Our studies suggest that such functional variants may be common and may help to refine the search for genes involved in complex behavioral disorders.


Subject(s)
Aggression/physiology , Gene Expression Regulation/genetics , Genetic Predisposition to Disease , MicroRNAs/physiology , Polymorphism, Genetic/genetics , RNA, Messenger/genetics , Receptor, Serotonin, 5-HT1B/genetics , Ethnicity/genetics , Female , Genotype , HeLa Cells , Humans , Luciferases/genetics , Male , Molecular Sequence Data , Sequence Analysis, RNA , Sex Factors , Transfection/methods
8.
Braz J Med Biol Res ; 37(3): 295-9, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15060693

ABSTRACT

Biotinidase deficiency is an inherited metabolic disorder characterized by neurological and cutaneous symptoms. Fortunately, it can be treated and the symptoms prevented by oral administration of the vitamin biotin. Using dried blood-soaked filter paper cards, biotinidase activity was determined in the sera of 225,136 newborns in Brazil. Mutation analysis performed on DNA from 21 babies with low serum biotinidase activity confirmed that 3 had profound biotinidase deficiency (less than 10% of mean normal sera biotinidase activity), 10 had partial biotinidase deficiency (10 to 30% of mean normal serum activity), 1 was homozygous for partial biotinidase deficiency, 4 were heterozygous for either profound or partial deficiency, and 3 were normal. Variability in serum enzyme activities and discrepancies with mutation analyses were probably due to inappropriate handling and storage of samples sent to the laboratory. Obtaining an appropriate control serum at the same time as that of the suspected child will undoubtedly decrease the false-positive rate (0.09%). Mutation analysis can be used to confirm the genotype of these children. The estimated incidence of biotinidase deficiency in Brazil is about 1 in 9,000, higher than in most other countries. Screening and treatment of biotinidase deficiency are effective and warranted. These results strongly suggest that biotinidase deficiency should be included in the newborn mass screening program of Brazil.


Subject(s)
Biotinidase Deficiency/diagnosis , Mutation/genetics , Neonatal Screening , Biotinidase Deficiency/epidemiology , Biotinidase Deficiency/genetics , Brazil/epidemiology , Female , Genotype , Humans , Incidence , Infant, Newborn , Male
9.
Braz. j. med. biol. res ; 37(3): 295-299, Mar. 2004. tab
Article in English | LILACS | ID: lil-356615

ABSTRACT

Biotinidase deficiency is an inherited metabolic disorder characterized by neurological and cutaneous symptoms. Fortunately, it can be treated and the symptoms prevented by oral administration of the vitamin biotin. Using dried blood-soaked filter paper cards, biotinidase activity was determined in the sera of 225,136 newborns in Brazil. Mutation analysis performed on DNA from 21 babies with low serum biotinidase activity confirmed that 3 had profound biotinidase deficiency (less than 10 percent of mean normal sera biotinidase activity), 10 had partial biotinidase deficiency (10 to 30 percent of mean normal serum activity), 1 was homozygous for partial biotinidase deficiency, 4 were heterozygous for either profound or partial deficiency, and 3 were normal. Variability in serum enzyme activities and discrepancies with mutation analyses were probably due to inappropriate handling and storage of samples sent to the laboratory. Obtaining an appropriate control serum at the same time as that of the suspected child will undoubtedly decrease the false-positive rate (0.09 percent). Mutation analysis can be used to confirm the genotype of these children. The estimated incidence of biotinidase deficiency in Brazil is about 1 in 9,000, higher than in most other countries. Screening and treatment of biotinidase deficiency are effective and warranted. These results strongly suggest that biotinidase deficiency should be included in the newborn mass screening program of Brazil.


Subject(s)
Humans , Male , Female , Infant, Newborn , Biotinidase Deficiency/diagnosis , Mutation , Neonatal Screening , Brazil , Biotinidase Deficiency/epidemiology , Biotinidase Deficiency/genetics , Genotype , Incidence
11.
J Immunol ; 166(5): 2982-91, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11207247

ABSTRACT

The 524--543 region of glutamic acid decarboxylase (GAD65), GAD65(524--543), is one of the first fragments of this islet Ag to induce proliferative T cell responses in the nonobese diabetic (NOD) mouse model of spontaneous autoimmune diabetes. Furthermore, NOD mice given tolerogenic doses of GAD65(524--543) are protected from spontaneous and cyclophosphamide-induced diabetes. In this study, we report that there are at least two I-A(g7)-restricted determinants present in the GAD65(524--543) sequence, each capable of recruiting unique T cell repertoires characterized by distinct TCR V beta gene use. CD4(+) T cells arise spontaneously in young NOD mice to an apparently dominant determinant found within the GAD65 peptide 530--543 (p530); however, T cells to the overlapping determinant 524-538 (p524) dominate the response only after immunization with GAD65(524--543). All p530-responsive T cells used the V beta 4 gene, whereas the V beta 12 gene is preferentially used to encode the TCR of p524-responsive T cell populations. T cell clones and hybridomas from both of these T cell groups were responsive to APC pulsed with GAD65(524--543) or whole rGAD65. p524-reactive cells appeared to be regulatory upon adoptive transfer into young NOD mice and could inhibit insulin-dependent diabetes mellitus development, although they were unable to produce IL-4, IL-10, or TGF beta upon antigenic challenge. Furthermore, we found that i.p. injection with p524/IFA was very effective in providing protection from cyclophosphamide-induced insulin-dependent diabetes mellitus. These data demonstrate that the regulatory T cells elicited by immunizing with GAD65(524--543) are unique and distinct from those that arise from spontaneous endogenous priming, and that T cells to this limited region of GAD65 may be either regulatory or pathogenic.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Epitopes, T-Lymphocyte/immunology , Genes, T-Cell Receptor beta , Glutamate Decarboxylase/immunology , Isoenzymes/immunology , Receptors, Antigen, T-Cell, alpha-beta/biosynthesis , Receptors, Antigen, T-Cell, alpha-beta/genetics , Adoptive Transfer , Amino Acid Motifs/genetics , Amino Acid Motifs/immunology , Amino Acid Sequence , Animals , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/transplantation , Cell Line , Clone Cells , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/prevention & control , Female , Gene Rearrangement, beta-Chain T-Cell Antigen Receptor , Glutamate Decarboxylase/administration & dosage , Glutamate Decarboxylase/metabolism , Hybridomas , Injections, Subcutaneous , Isoenzymes/administration & dosage , Isoenzymes/metabolism , Lymphocyte Activation/genetics , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Molecular Sequence Data , Peptide Fragments/administration & dosage , Peptide Fragments/genetics , Peptide Fragments/immunology , Receptors, Antigen, T-Cell, alpha-beta/deficiency , Tumor Cells, Cultured
12.
Cancer Nurs ; 23(1): 6-11, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10673802

ABSTRACT

This article explores the meaning to women with breast cancer of "not giving in". Giorgi's phenomenological method was applied, and data were collected through open interviews. Ten women with breast cancer participated. The analysis resulted in a general structure of the phenomenon studied, including six key constituents: accepting the challenge to go on living, working actively on the healing process, finding something important to live for, gaining insights about life itself, experiencing awareness and avoidance, and introducing radical change in life. The results are consistent with literature about strategies in facing death and development as human conditions. Understanding the phenomenon of "not giving in" seems to be crucial for nurses in helping women with breast cancer to mobilize the inner power to survive and develop as human beings.


Subject(s)
Attitude to Health , Breast Neoplasms/psychology , Life Change Events , Women/psychology , Breast Neoplasms/nursing , Female , Humans , Interviews as Topic/methods , Patient Selection
13.
Nurs Sci Q ; 9(3): 115-20, 1996.
Article in English | MEDLINE | ID: mdl-8850984

ABSTRACT

The purpose of this article is to describe essential characteristics of an excellent nurse as perceived by women with breast cancer. A descriptive-exploratory research design was used, and 10 Danish women who had breast cancer surgery and treatment more than one year previously and who were still in secondary treatment but not hospitalized participated in semi-structured interviews. Four main concepts were identified: The excellent nurse was perceived as competent, compassionate, courageous, and concordant. Concordance was more important to the subjects than expected and was described as directly related to their perception of an excellent nurse and excellence in nursing.


Subject(s)
Breast Neoplasms/psychology , Clinical Competence , Nurse-Patient Relations , Oncology Nursing/standards , Patient Satisfaction , Adult , Breast Neoplasms/nursing , Breast Neoplasms/surgery , Female , Humans , Middle Aged , Nursing Methodology Research , Oncology Nursing/methods
14.
Pflege ; 8(2): 163-72, 1995 Jun.
Article in German | MEDLINE | ID: mdl-7620057

ABSTRACT

The caring moment and the phenomenon of the green thumb for nursing in Sweden. People who have a special gift for gardening are sometimes described as having a green thumb. Likewise, some nurses have a green thumb for nursing. The aims of this study were to identify and describe the characteristics of green-thumb nurses and of caring situations. A descriptive-exploratory design was used and 16 nurses, recruited by their superiors, participated in semi-structured interviews. The findings revealed that the green-thumb nurse is competent, compassionate, and courageous. The essence of the caring moment was identified as the green-thumb nurse's ability to act on the spur of the moment, using her competence, compassion, and courage.


Subject(s)
Aptitude , Episode of Care , Humans , Nurses/psychology
15.
Nurs Sci Q ; 6(2): 98-104, 1993.
Article in English | MEDLINE | ID: mdl-8502442

ABSTRACT

People who have a special gift for gardening are sometimes described as having a green thumb. Likewise, some nurses have a green thumb for nursing. The aims of this study were to identify and describe the characteristics of green-thumb nurses and of caring situations. A descriptive-exploratory design was used, and 16 nurses, recruited by their superiors, participated in semi-structured interviews. The findings revealed that the green-thumb nurse is competent, compassionate, and courageous. The essence of the caring moment was identified as the green-thumb nurse's ability to act on the spur of the moment, using her competence, compassion, and courage.


Subject(s)
Caregivers/psychology , Clinical Competence/standards , Nurse-Patient Relations , Nurses/psychology , Adult , Female , Humans , Middle Aged , Nursing Methodology Research , Self Concept , Sweden
SELECTION OF CITATIONS
SEARCH DETAIL
...